If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJames Halstead Regulatory News (JHD)

Share Price Information for James Halstead (JHD)

Share Price is delayed by 15 minutes
Get Live Data
122.60    -2.20 (-1.76%)
Bid:
122.80
Ask:
123.40
Spread: 0.60 (0.489%)
Market Cap: £510.52m
JHD Live PriceLast checked at - London Stock Exchange

Intraday James Halstead Share Chart

Trading Update

29 Jul 2025 07:00

RNS Number : 8873S
James Halstead PLC
29 July 2025
 

 

29 July 2025

 

 

JAMES HALSTEAD PLC (the "Company")

 

Trading Update

James Halstead plc, the commercial flooring manufacturer and international distributor, is providing the following trading update ahead of its results for the year ended 30 June 2025.

 

The Company sells, for the most part, commercial flooring across the world and has seen continued confidence in the segment of resilient sheet flooring but has experienced headwinds against sales of luxury vinyl tile (LVT) principally in Europe, the Company has however successfully managed to grow its market share in the UK. Profit before tax is in line with expectations.

 

Sales in the UK, our largest market, have improved compared to the prior financial year. Having reported that in the prior financial year there was a 5% decline versus the comparative, it is pleasing to note that our performance this year has seen this decline more than fully reverse. This is despite a degree of de-stocking by some customers, particularly those with exposure to the UK domestic carpet market.

 

Sales volumes of LVT have increased, albeit modestly, in a market segment that has seen a large decline in demand. Sales of Polyflor branded LVT products have held up due to their quality and value together with our widely accepted reputation for sustainability and environmental excellence; factors that have helped increase our market share. LVT and sheet vinyl continue to displace carpet sales in the UK market.

 

Notwithstanding this backdrop and solid UK performance, our internal expectations for the UK were higher. An anticipated uplift in demand in the education, healthcare and the prison sectors has not, yet, materialised though sales into the aged care and affordable housing sectors are performing satisfactorily.

 

In Europe, particularly in France and Holland, there has been muted activity in consumer spending which has affected refurbishment demand and new store openings in the retail sector. This has impacted LVT sales and volume declines were further compounded by increased focus of government budgets towards national security, diverting spending away from such areas as construction and social housing.

 

The products we sell are still regarded as market leading but the year has required reacting to a lower level of sales by tight cost control. In this regard, the simple model of holding stock within our distribution chain to supply demand is tried and tested around the globe.

 

In our Rest of World markets, sales have generally been more positive with very good growth, especially in the Americas, the Middle East and Mediterranean regions. Additionally, South Asia has seen the growth of recent years continue and is 38% ahead of the comparative of last year.

 

Notwithstanding the slower sales, the Group's focus on manufacturing efficiency and tight cost control of overheads have protected margins.

 

Operationally, there has been disruption to global trade routes and shipping movements with the uncertainty of tariffs on sales into the USA which has affected deliveries into many markets. However, these uncertainties have been positive regarding the sale of our UK manufactured goods into the USA, as customers seek alternative suppliers to replace products imported from countries where much higher tariffs have been imposed and with continuing uncertainly. This increased demand is despite an additional 10% duty cost to importers of our UK products.

 

In summary, the Company anticipates that sales will be marginally below the 2024 comparative with profit slightly below last year's record levels; although remaining within the range of market expectations. Cash generation alongside reserves continue to underpin an ungeared balance sheet, which remains strong.

 

The Board is confident that the prospects remain solid despite the recent external challenges and side winds.

 

The Company expects to announce its results for the year ended 30 June 2025 towards the end of September 2025.

 

 

 

 

 

Enquiries:

 

James Halstead plc

Tel: 0161 767 2500

Mark Halstead, Executive Chairman

Gordon Oliver, Chief Executive

David Drillingcourt, Finance Director

 

Hudson Sandler

Tel: 020 7796 4133

Nick Lyon / Nick Moore

Panmure Liberum (Nomad and Joint Broker)

Tel: 020 7886 2500

Ed Mansfield / Tom Scrivens

Zeus (Joint Broker)

Ben Thorne / Fraser Marshall

 

Tel: 020 3829 5000

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTPKFBQCBKDPOB
Date   Source Headline
23rd Aug 20071:21 pmRNSAdditional Listing
16th Aug 20073:00 pmRNSAIM Rule 26
25th Jul 20077:00 amRNSPre-close Trading Update
24th Jul 20074:18 pmRNSDirectors' Dealings
29th Jun 200711:02 amRNSTotal Voting Rights
12th Jun 20074:19 pmRNSDirector/PDMR Shareholding
3rd May 200711:33 amRNSTrading Statement
26th Apr 20074:52 pmRNSBlock listing returns
28th Mar 20077:01 amRNSInterim Results
14th Mar 20074:47 pmRNSNotice of Results
21st Dec 20065:43 pmRNSTotal Voting Rights
4th Dec 200612:23 pmRNSDividend Declaration
1st Dec 20067:01 amRNSAGM Statement
15th Nov 20067:30 amRNSSite visit
18th Oct 20067:01 amRNSIssue of Shares
17th Oct 200610:43 amRNSIssue of Shares
22nd Sep 20067:00 amRNSPreliminary Results
12th Sep 200610:47 amRNSNotice of Results
3rd Jul 20068:44 amRNSChange of Adviser
30th Mar 200611:29 amRNSDirector's shareholding
30th Mar 20067:01 amRNSInterim Results
2nd Mar 20067:01 amRNSNotice of Results
27th Feb 20067:00 amRNSShare sub-division
9th Feb 20062:26 pmRNSShare sub-division
11th Jan 20061:06 pmRNSDirector's shareholding
9th Jan 20062:59 pmRNSGrant of options
6th Jan 200612:58 pmRNSExercise of options etc.
2nd Dec 20058:00 amRNSAGM Statement
2nd Nov 20057:00 amRNSExercise of options etc.
14th Oct 20054:18 pmRNSDirector's shareholding
4th Oct 20057:00 amRNSFinal Results
16th Sep 20053:09 pmRNSNotice of Results
14th Sep 20052:57 pmRNSNotice of Results
3rd Aug 20059:21 amRNSBlock listing application
1st Jun 200512:14 pmRNSBlocklisting Interim Review
4th May 20052:32 pmRNSDirector Shareholding
30th Mar 20057:00 amRNSInterim Results
24th Mar 20059:13 amRNSNotice of Results
14th Jan 20057:00 amRNSB Share and C Share Elections

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.